HealthXL community members and industry leaders from pharma, digital health companies and decentralized trials providers have come together to create this new open-access tool.
The tool helps sponsors select the best digital measurement technologies for clinical trial use in each particular trial. It also offers vendors a way to prepare a documentation package to support the sponsor evaluation process.
This initiative continues to build upon the earlier work of the DiME V3 framework, the CTTI checklist and the HealthXL Vendor Assessment Guide.
In combination with the 2021 HealthXL Vendor Assessment, this new tool can help you get a broad and deep evaluation of technology and vendor readiness for clinical trial use.
Thank you to all our contributors: